FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912742786> ?p ?o ?g. }

• W2912742786 endingPage "524" @default.
• W2912742786 startingPage "524" @default.
• W2912742786 abstract "Pancreatic cancer (PC) is a complex, heterogeneous disease with a dismal prognosis. Current therapies have failed to improve survival outcomes, urging the need for discovery of novel targeted treatments. Bispidinone derivatives have yet to be investigated as cytotoxic agents against PC cells. The cytotoxic effect of four bispidinone derivatives (BisP1: 1,5-diphenyl-3,7-bis(2-hydroxyethyl)-3,7-diazabicyclo[3.3.1]nonan-9-one; BisP2: 3,7-bis-(2-(S)-amino-4-methylsulfanylbutyryl)-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one dihydrochloride; BisP3: [2-{7-[2-(S)-tert-butoxycarbonylamino-3-(1H-indol-3-yl)-propionyl]-9-oxo-1,5-diphenyl-3,7-diazabicyclo[3.3.1]non-3-yl}-1-(S)-(1H-indol-3-ylmethyl)-2-oxoethyl]-carbamic acid tertbutyl ester; BisP4: 3,7-bis-[2-(S)-amino-3-(1H-indol-3-yl)-propionyl]-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one dihydrochloride) was assessed against PC cell lines (MiaPaca-2, CFPAC-1 and BxPC-3). Cell viability was assessed using a Cell Counting Kit-8 (CCK-8) colorimetric assay, while apoptotic cell death was confirmed using fluorescence microscopy and flow cytometry. Initial viability screening revealed significant cytotoxic activity from BisP4 treatment (1 µM–100 µM) on all three cell lines, with IC50 values for MiaPaca-2, BxPC-3, and CFPAC-1 16.9 µM, 23.7 µM, and 36.3 µM, respectively. Cytotoxic treatment time-response (4 h, 24 h, and 48 h) revealed a 24 h treatment time was sufficient to produce a cytotoxic effect on all cell lines. Light microscopy evaluation (DAPI staining) of BisP4 treated MiaPaca-2 PC cells revealed dose-dependent characteristic apoptotic morphological changes. In addition, flow cytometry confirmed BisP4 induced apoptotic cell death induction of activated caspase-3/-7. The bispidinone derivative BisP4 induced an apoptosis-mediated cytotoxic effect on MiaPaca-2 cell lines and significant cytotoxicity on CFPAC-1 and BxPC-3 cell lines. Further investigations into the precise cellular mechanisms of action of this class of compounds are necessary for potential development into pre-clinical trials." @default.
• W2912742786 created "2019-02-21" @default.
• W2912742786 creator A5006215548 @default.
• W2912742786 creator A5008344145 @default.
• W2912742786 creator A5014260704 @default.
• W2912742786 creator A5017145933 @default.
• W2912742786 creator A5026633618 @default.
• W2912742786 creator A5044178926 @default.
• W2912742786 creator A5051786224 @default.
• W2912742786 creator A5056872570 @default.
• W2912742786 creator A5063657901 @default.
• W2912742786 creator A5085877179 @default.
• W2912742786 creator A5086242907 @default.
• W2912742786 date "2019-01-31" @default.
• W2912742786 modified "2023-09-23" @default.
• W2912742786 title "The Bispidinone Derivative 3,7-Bis-[2-(S)-amino-3-(1H-indol-3-yl)-propionyl]-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one Dihydrochloride Induces an Apoptosis-Mediated Cytotoxic Effect on Pancreatic Cancer Cells In Vitro" @default.
• W2912742786 cites W1500036797 @default.
• W2912742786 cites W1879762752 @default.
• W2912742786 cites W1965677872 @default.
• W2912742786 cites W1967479638 @default.
• W2912742786 cites W1968812902 @default.
• W2912742786 cites W1987313243 @default.
• W2912742786 cites W1987466720 @default.
• W2912742786 cites W1995037393 @default.
• W2912742786 cites W2004431524 @default.
• W2912742786 cites W2028445259 @default.
• W2912742786 cites W2030509020 @default.
• W2912742786 cites W2038479411 @default.
• W2912742786 cites W2040535871 @default.
• W2912742786 cites W2041343513 @default.
• W2912742786 cites W2072350111 @default.
• W2912742786 cites W2074705874 @default.
• W2912742786 cites W2082983886 @default.
• W2912742786 cites W2085308878 @default.
• W2912742786 cites W2102509488 @default.
• W2912742786 cites W2115658806 @default.
• W2912742786 cites W2117692326 @default.
• W2912742786 cites W2118143190 @default.
• W2912742786 cites W2120593159 @default.
• W2912742786 cites W2132352483 @default.
• W2912742786 cites W2138155367 @default.
• W2912742786 cites W2141932308 @default.
• W2912742786 cites W2146583343 @default.
• W2912742786 cites W2161884651 @default.
• W2912742786 cites W2170552969 @default.
• W2912742786 cites W2314914862 @default.
• W2912742786 cites W2417286343 @default.
• W2912742786 doi "https://doi.org/10.3390/molecules24030524" @default.
• W2912742786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6384835" @default.
• W2912742786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30709047" @default.
• W2912742786 hasPublicationYear "2019" @default.
• W2912742786 type Work @default.
• W2912742786 sameAs 2912742786 @default.
• W2912742786 citedByCount "5" @default.
• W2912742786 countsByYear W29127427862020 @default.
• W2912742786 countsByYear W29127427862021 @default.
• W2912742786 countsByYear W29127427862023 @default.
• W2912742786 crossrefType "journal-article" @default.
• W2912742786 hasAuthorship W2912742786A5006215548 @default.
• W2912742786 hasAuthorship W2912742786A5008344145 @default.
• W2912742786 hasAuthorship W2912742786A5014260704 @default.
• W2912742786 hasAuthorship W2912742786A5017145933 @default.
• W2912742786 hasAuthorship W2912742786A5026633618 @default.
• W2912742786 hasAuthorship W2912742786A5044178926 @default.
• W2912742786 hasAuthorship W2912742786A5051786224 @default.
• W2912742786 hasAuthorship W2912742786A5056872570 @default.
• W2912742786 hasAuthorship W2912742786A5063657901 @default.
• W2912742786 hasAuthorship W2912742786A5085877179 @default.
• W2912742786 hasAuthorship W2912742786A5086242907 @default.
• W2912742786 hasBestOaLocation W29127427861 @default.
• W2912742786 hasConcept C109316439 @default.
• W2912742786 hasConcept C153911025 @default.
• W2912742786 hasConcept C154317977 @default.
• W2912742786 hasConcept C185592680 @default.
• W2912742786 hasConcept C190283241 @default.
• W2912742786 hasConcept C202751555 @default.
• W2912742786 hasConcept C2777752497 @default.
• W2912742786 hasConcept C53227056 @default.
• W2912742786 hasConcept C54355233 @default.
• W2912742786 hasConcept C553184892 @default.
• W2912742786 hasConcept C55493867 @default.
• W2912742786 hasConcept C71240020 @default.
• W2912742786 hasConcept C81885089 @default.
• W2912742786 hasConcept C86803240 @default.
• W2912742786 hasConceptScore W2912742786C109316439 @default.
• W2912742786 hasConceptScore W2912742786C153911025 @default.
• W2912742786 hasConceptScore W2912742786C154317977 @default.
• W2912742786 hasConceptScore W2912742786C185592680 @default.
• W2912742786 hasConceptScore W2912742786C190283241 @default.
• W2912742786 hasConceptScore W2912742786C202751555 @default.
• W2912742786 hasConceptScore W2912742786C2777752497 @default.
• W2912742786 hasConceptScore W2912742786C53227056 @default.
• W2912742786 hasConceptScore W2912742786C54355233 @default.
• W2912742786 hasConceptScore W2912742786C553184892 @default.
• W2912742786 hasConceptScore W2912742786C55493867 @default.
• W2912742786 hasConceptScore W2912742786C71240020 @default.
• W2912742786 hasConceptScore W2912742786C81885089 @default.
• W2912742786 hasConceptScore W2912742786C86803240 @default.

• next